Masayuki Baba

Siponimod versus placebo in secondary progressive multiple sclerosis (EXPAND): a double-blind, randomised, phase 3 study

Ludwig Kappos, Amit Bar‐Or, Bruce Cree et al. · The Lancet · 2018 · 896 citations

Neurological Disorder, Clinical Neurology, Clinical Trials +9

Subcutaneous immunoglobulin for maintenance treatment in chronic inflammatory demyelinating polyneuropathy (PATH): a randomised, double-blind, placebo-controlled, phase 3 trial

Ivo N. van Schaik, Vera Bril, Nan van Geloven et al. · The Lancet Neurology · 2017 · 258 citations · Full text

Subcutaneous Immunoglobulin, Autoimmune Disease, Chronic Inflammatory +12

Overview of clinical experiences on carbon ion radiotherapy at NIRS

Hirohiko Tsujii, Jun-etsu Mizoe, Tadashi Kamada et al. · Radiotherapy and Oncology · 2004 · 211 citations

Adaptive Radiotherapy, Radiation Medicine, Oncology +5

Clinical Results of Carbon Ion Radiotherapy at NIRS

Hirohiko Tsujii, Jun‐etsu Mizoe, Tadashi Kamada et al. · Journal of Radiation Research · 2007 · 210 citations · Full text

Radiation Medicine, Health Sciences, Radiation Therapy +11

Effect of Aminoguanidine on Functional and Structural Abnormalities in Peripheral Nerve of STZ-Induced Diabetic Rats

Soroku Yagihashi, Mikiko Kamijo, Masayuki Baba et al. · Diabetes · 1992 · 181 citations

Glycobiology, Peripheral Nerve, Peripheral Nervous System +19